The FDA approved Bkemv (eculizumab-aeeb) as the first biosimilar to Soliris (eculizumab) for 2 rare diseases. It was also ...
A literature review revealed new data demonstrating that biosimilar-to-biosimilar switching is safe and effective.
Alvotech and Teva have launched Simlandi in the US; Xbrane Biopharma and STADA Arzneimitel partner with Valorum Biologics to ...
Lakesha Farmer from Cencora discusses innovative pricing and reimbursement models incentivizing biosimilar adoption and ...
A real-world study of the use of adalimumab biosimilars in pediatric inflammatory bowel disease (IBD) in Sicily found “high rates” of clinical remission and treatment persistence, and no unexpected ...
Number 3: The FDA approved the first 2 biosimilars referencing Eylea (aflibercept)—Yesafili (aflibercept-jbvf) and Opuviz ...
Posters from Digestive Disease Week (DDW) on the ongoing LIBERTY-CD trial assessing Zymfentra, a subcutaneous infliximab product, compared with intravenous infliximab treatment in Crohn disease show ...
In the IQVIA Use of Medicines in the US 2024 report, biosimilar were found to be large contributors to lower drug costs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback